Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ -20.51MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
Sector
Industry
History
$ 0.67Close
$ 0.63 - $ 2.91 52-Week Range
Ticker Information
Ticker
ITRMCompany Name
ITERUM THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQITERUM THERAPEUTICS PLC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ITRM - EBITDA Historical data
| Date | Depreciation, Amortization & Accretion | Earning Before Interest & Taxes (EBIT) | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) |
|---|---|---|---|
| 6/30/2025 | $ 969K | $ -21.48M | $ -20.51M |
| 3/31/2025 | $ 626K | $ -19.74M | $ -19.12M |
| 12/31/2024 | $ 284K | $ -22.01M | $ -21.73M |
| 9/30/2024 | $ 463K | $ -28.14M | $ -27.68M |
| 6/30/2024 | $ 891K | $ -26.19M | $ -25.3M |
| 3/31/2024 | $ 1.32M | $ -33.53M | $ -32.21M |
| 12/31/2023 | $ 1.75M | $ -36.33M | $ -34.58M |
| 9/30/2023 | $ 1.75M | $ -29.58M | $ -27.84M |
| 6/30/2023 | $ 1.76M | $ -55.21M | $ -53.45M |
| 3/31/2023 | $ 1.78M | $ -49.1M | $ -47.33M |
Key Performance Insights, Last 5 Years
- ITERUM THERAPEUTICS PLC's latest trailing twelve months (TTM) EBITDA stands at $ -52.27M.
- Over the past 5 years, ITERUM THERAPEUTICS PLC's average EBITDA has been $ -42.92M.
- The median EBITDA for ITERUM THERAPEUTICS PLC during this period was $ -35.29M
- ITERUM THERAPEUTICS PLC reached its highest EBITDA over the past 5 years at $ 11.1M.
- The lowest EBITDA recorded by ITERUM THERAPEUTICS PLC in the same timeframe $ -118.53M
Similar metrics to EBITDA:
- Depreciation, Amortization & Accretion - [Cash Flow Statement] A component of operating cash flow [NCFO] representing the aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a non-cash item, the net amount is added back to net income when calculating cash provided by operations.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Earning Before Interest & Taxes (EBIT) - [Income Statement] Earnings before interest and taxes measures a company's net income [NetInc] prior to the deduction of interest [IntExp] and tax expenses [TaxExp].
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].EBIT + DepAmor
(=) EBITDA EBITDA for ITERUM THERAPEUTICS PLC is calculated as follows: EBIT [ $ -52.43M ] + DepAmor [ $ 161K ]
(=) EBITDA [ $ -52.27M ] ITRM - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years
$ -118.53M
Minimum
Mar 31, 2021
$ 11.1M
Maximum
Mar 31, 2022
$ -42.92M
Average
$ -35.29M
Median
EBITDA Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.79M with a standard deviation of $ 166.94M.
The following table provides additional summary stats:
EBITDA in the Market:
| filtered constituents | 3.25K |
|---|---|
| min | $ -493.3M |
| max | $ 590.6M |
| average | $ 58.79M |
| median | $ 8.83M |
| std | $ 166.94M |